Observational study on the response of tenofovir monotherapy versus tenofovir plus telbivudine dual therapy in patients with hepatitis B virus related acute on chronic liver failure

INTRODUCTION: HBV is major health problem globally due to complications, including ACLF, cirrhosis and hepa¬tocellular carcinoma. ACLF due to exacerbation of CHB is associate with 30%-70% mortality. Reduction of HBV-DNA is therefore a target of therapy in ACLF-B. METHODS: Patients with spontaneous r...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Family Med Prim Care
Autors principals: Manik, Abul H, Malakar, Debraj, Noor-E-Alam, Sheikh M, Mahtab, Mamun A, Das, Dulal C, Mamun, Ayub A, Khan, Sakirul, Akbar, Mohammad Fazle, Rahman, Zakiur, Rahman, Salimur
Format: Artigo
Idioma:Inglês
Publicat: Wolters Kluwer - Medknow 2021
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8284233/
https://ncbi.nlm.nih.gov/pubmed/34322441
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/jfmpc.jfmpc_2300_20
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars